Log in to save to my catalogue

EML4‑ALK fusion gene in non‑small cell lung cancer (Review)

EML4‑ALK fusion gene in non‑small cell lung cancer (Review)

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9344266

EML4‑ALK fusion gene in non‑small cell lung cancer (Review)

About this item

Full title

EML4‑ALK fusion gene in non‑small cell lung cancer (Review)

Publisher

Athens: Spandidos Publications

Journal title

Oncology letters, 2022-08, Vol.24 (2), p.1, Article 277

Language

English

Formats

Publication information

Publisher

Athens: Spandidos Publications

More information

Scope and Contents

Contents

Non-small cell lung cancer (NSCLC) is a malignant tumor with a high morbidity and mortality rate that is a threat to human health. With the development of molecular targeted research, breakthroughs have been made on the molecular mechanism of lung cancer. The echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) fus...

Alternative Titles

Full title

EML4‑ALK fusion gene in non‑small cell lung cancer (Review)

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9344266

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9344266

Other Identifiers

ISSN

1792-1074

E-ISSN

1792-1082

DOI

10.3892/ol.2022.13397

How to access this item